Azelastine
Links shared publicly online about this topic
Meda Receives FDA Approval of New Astepro (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
drugs.com — “Astepro (azelastine) is used to treat rhinitis symptoms. Includes Astepro side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 4, 2009 at 12:11 am By:
Meda Receives FDA Approval of Astepro (azelastine) Nasal Spray 0.15% Once-Daily Nasal Antihistamine - http://bit.ly/10rcwI
A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis
content.karger.com — “A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis” View full resource at content.karger.com
Most Recently Shared on August 23, 2011 at 2:28 pm By:
Azelastine and Levocabastine are effective and safe in the treatment of moderate-to-severe persistent allergic rhinitis http://t.co/idxc6cI
Astelin and Glaucoma: Is this nasal spray safe for patients with glaucoma?
intelihealth.com — “Astelin and Glaucoma: Is this nasal spray safe for patients with glaucoma?” View full resource at intelihealth.com
Most Recently Shared on April 4, 2010 at 6:58 pm By:
Astelin and Glaucoma: Is this nasal spray safe for patients with glaucoma? http://bit.ly/997rHn
Meda: Positive Study Results Presented For Dymista
medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patie” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2011 at 12:05 pm By:
Meda: Positive Study Results Presented For Dymista http://mnt.to/3SCB #entnews
Meda: Dymista filed with the FDA | Business Wire
businesswire.com — “Regulatory News A New Drug Application for a novel formulation of azelastine hydrochloride and fluticasone propionate, tentatively named “Dymist” View full resource at businesswire.com
Most Recently Shared on April 4, 2011 at 12:59 pm By:
Dymista (combination of fluticasone propionate/azelastine) filed with the FDA for seasonal allergic rhinitis by Meda - http://goo.gl/600KE
Meda: Positive Study Results Presented For Dymista
medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patie” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2011 at 4:47 pm By:
Meda: Positive Study Results Presented For Dymista: Meda (STO:MEDAA) announced positive results from a Phase III... http://bit.ly/dLca5L
Allergy/Immunology Article | Rhinitis, Vasomotor
mdlinx.com — “Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis” View full resource at mdlinx.com
Most Recently Shared on March 30, 2011 at 3:54 pm By:
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride... http://bit.ly/e5FB5p #Allergy
Otolaryngology Article | Rhinitis
mdlinx.com — “A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis” View full resource at mdlinx.com
Most Recently Shared on August 15, 2011 at 6:58 am By:
A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocab... http://t.co/jbxNckJ #ENT
Allergy/Immunology Article | Rhinitis
mdlinx.com — “A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis” View full resource at mdlinx.com
Most Recently Shared on August 16, 2011 at 9:11 am By:
A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Lev... http://t.co/TtIhWSj #Allergy
Meda Pharma introduces 5ml nasal spray Rhinolast Allergy - Pharmaceutical Business Review
pharmaceutical-business-review.com — “Meda Pharmaceuticals has introduced 5ml nasal spray Rhinolast Allergy as an over-the-counter therapy to help children from the age of five tackle thei” View full resource at pharmaceutical-business-review.com
Most Recently Shared on May 4, 2011 at 9:26 am By:
Meda Pharma introduces 5ml nasal spray Rhinolast Allergy http://bit.ly/jodOaD
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - ONA
oncologynurseadvisor.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitis” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 22, 2011 at 6:07 pm By:
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis http://goo.gl/fb/yp3o2
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - MPR
empr.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitis” View full resource at empr.com
Most Recently Shared on March 22, 2011 at 6:08 pm By:
MPR News: Phase 3 Study of Dymista for Seasonal Allergic Rhinitis: Meda announced positive results from its Phas... http://bit.ly/hpduGL
Phase 3 Results for Dymista for Allergic Rhinitis - ONA
oncologynurseadvisor.com — “Meda announced new results from its Phase 3 study of Dymista (azelastine HCl and fluticasone propionate; Meda) nasal spray for the treatment of allergic rhinitis.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 15, 2011 at 3:03 pm By:
Phase 3 Results for Dymista for Allergic Rhinitis http://goo.gl/fb/hqibE
FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon | #epharma #in | World of DTC Marketing.com
worldofdtcmarketing.com — “FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon | #epharma #in | World of DTC Marketing.com” View full resource at worldofdtcmarketing.com
Most Recently Shared on February 8, 2010 at 5:46 pm By:
FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon http://goo.gl/fb/FEYv #epharmain
Astepro nasal spray 0.15% approved for nasal allergy symptoms - MPR
empr.com — “The FDA has approved Astepro (azelastine HCl nasal spray, from Meda) 0.15%, a nasal antihistamine, for the relief of symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age.” View full resource at empr.com
Most Recently Shared on September 2, 2009 at 4:38 pm By:
MPR News: Astepro nasal spray 0.15% approved for nasal allergy symptoms: The FDA has approved Astepro (.. http://bit.ly/L02N5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Juan C. Ivancevich, MD
Allergist - Head Allergy & Immunology, Santa Isabel Clinic, Buenos Aires. Assistant Professor of Immunology, Medicine School, Universidad del Salvador, Buenos Aires. Member of the Board of Directors, World Allergy Organization. President of the South Cone Chapter on the Latin American Society of Allergy, Asthma & Immunology.
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
Advertisement

